Showing results (81-90 of 162) with videos related to
Sort By:
Pageof 17
Cancer Letters|November 13, 2018
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathwayKim De Veirman, Eline Menu, Ken Maes, et al.Immunological Reviews|July 9, 2003
Multiple myeloma biology: lessons from the 5TMM modelsKarin Vanderkerken, Kewal Asosingh, Peter Croucher, et al.British Journal of Cancer|May 16, 2019
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphomaAnke Maes, Ken Maes, Hendrik De Raeve, et al.Journal for Immunotherapy of Cancer|April 29, 2025
Immunopeptidomics identified antigens for mRNA-lipid nanoparticle vaccines with alpha-galactosylceramide in multiple myeloma therapyArne Van der Vreken, Fabien Thery, Chenggong Tu, et al.Current Gene Therapy|June 13, 2009
In search of the most suitable lentiviral shRNA systemTomas Jan Bos, Elke De Bruyne, Carlo Heirman, et al.Annals of the New York Academy of Sciences|June 12, 2010
Thymosin beta4 in multiple myeloma: friend or foeJo Caers, Eleonore Otjacques, Dirk Hose, et al.Blood Cancer Journal|December 18, 2023
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid LeukemiaRong Fan, Hatice Satilmis, Niels Vandewalle, et al.The Journal of Pathology|October 17, 2022
Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolismHatice Satilmis, Emma Verheye, Philip Vlummens, et al.Theranostics|May 22, 2024
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid LeukemiaNiels Vandewalle, Hatice Satilmis, Emma Verheye, et al.Cancer Research|December 21, 2017
Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant ProgressionEva De Smedt, Ken Maes, Stefaan Verhulst, et al.Pageof 17